Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03944902
Title CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients (BRCA)
Acronym BRCA
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
UCSF San Francisco California 94143 United States Details
MAYO Clinic Rochester Minnesota 55905 United States Details
Allegheny Health Network Research Institute Pittsburgh Pennsylvania 15224 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field